- Home
- LUNG vs FORA Comparison
LUNG vs FORA Comparison
Compare LUNG & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNG
- FORA
- Stock Information
- Founded
- LUNG 1995
- FORA 2014
- Country
- LUNG United States
- FORA United States
- Employees
- LUNG N/A
- FORA 37
- Industry
- LUNG Industrial Specialties
- FORA Computer Software: Prepackaged Software
- Sector
- LUNG Health Care
- FORA Technology
- Exchange
- LUNG Nasdaq
- FORA Nasdaq
- Market Cap
- LUNG 65.6M
- FORA 69.4M
- IPO Year
- LUNG 2020
- FORA N/A
- Fundamental
- Price
- LUNG $1.59
- FORA $2.26
- Analyst Decision
- LUNG Buy
- FORA Strong Buy
- Analyst Count
- LUNG 7
- FORA 1
- Target Price
- LUNG $7.66
- FORA $5.00
- AVG Volume (30 Days)
- LUNG 480.4K
- FORA 75.0K
- Earning Date
- LUNG 10-29-2025
- FORA 11-12-2025
- Dividend Yield
- LUNG N/A
- FORA N/A
- EPS Growth
- LUNG N/A
- FORA N/A
- EPS
- LUNG N/A
- FORA N/A
- Revenue
- LUNG $90,549,000.00
- FORA $25,031,040.00
- Revenue This Year
- LUNG $10.30
- FORA $47.82
- Revenue Next Year
- LUNG $14.72
- FORA $10.11
- P/E Ratio
- LUNG N/A
- FORA N/A
- Revenue Growth
- LUNG 18.24
- FORA 18.59
- 52 Week Low
- LUNG $1.47
- FORA $1.64
- 52 Week High
- LUNG $9.37
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- LUNG 39.52
- FORA 60.10
- Support Level
- LUNG $1.54
- FORA $2.20
- Resistance Level
- LUNG $1.63
- FORA $2.39
- Average True Range (ATR)
- LUNG 0.12
- FORA 0.13
- MACD
- LUNG 0.02
- FORA 0.02
- Stochastic Oscillator
- LUNG 12.90
- FORA 72.92
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.